the Diagnostic value of combined detection of serum NLR and CRP for migraine patients in attack stage: A prospective study
Running title: serum NLR and CRP for migraine patients
Ključne reči:
0
Sažetak
0
Reference
1. Jat, M.I., et al., Prevalence of Migraine among patients of Depressive Disorder. Pak J Med Sci, 2018. 34(4): p. 964-967.
2. Ghavami, Y., et al., Migraine features in patients with Meniere's disease. Laryngoscope, 2016. 126(1): p. 163-8.
3. Czapińska-Ciepiela, E., Treatment of migraine in a patient with epilepsy. Wiad Lek, 2018. 71(9): p. 1793-1802.
4. Karikari, T.K., et al., Commentary: Global, regional, and national burden of neurological disorders during 1990-2015: a systematic analysis for the Global Burden of Disease Study 2015. Front Neurol, 2018. 9: p. 201.
5. Hu, L., et al., Different Chinese patent medicine therapies for migraine: A protocol for systematic review and network meta-analysis. Medicine (Baltimore), 2021. 100(2): p. e24179.
6. Cameron, C., et al., Triptans in the Acute Treatment of Migraine: A Systematic Review and Network Meta-Analysis. Headache, 2015. 55 Suppl 4: p. 221-35.
7. Edvinsson, L., The Trigeminovascular Pathway: Role of CGRP and CGRP Receptors in Migraine. Headache, 2017. 57 Suppl 2: p. 47-55.
8. Abd Al-Kareem, T.A., S.A. Hassan, and S.M. Abdalhadi, Polycystic Ovary Syndrome: pathogenesis, management, and treatment with metals and organic compounds. Cell Mol Biomed Rep, 2024. 4(1): p. 54-64.
9. Li, W. and Y. Wang, The progress and development trends on stress granules in the world and China during the past 35 years. Cell Mol Biomed Rep, 2024. 4(1): p. 17-29.
10. Albeizanee, S., et al., Pathophysiological aspects of antioxidant glutathione system components during covid-19 infection; a patient-based survey and clinical relevance. Cell Mol Biomed Rep, 2025. 5(2): p. 103-112.
11. El-Seedy, A. and V. Ladeveze, CFTR complex alleles and phenotypic variability in cystic fibrosis disease: CFTR complex alleles. Cellular and Molecular Biology, 2024. 70(8): p. 244-260.
12. Panconesi, A., M.L. Bartolozzi, and L. Guidi, Migraine pain: reflections against vasodilatation. J Headache Pain, 2009. 10(5): p. 317-25.
13. Ramachandran, R., Neurogenic inflammation and its role in migraine. Semin Immunopathol, 2018. 40(3): p. 301-314.
14. Nehring, S.M., A. Goyal, and B.C. Patel, C Reactive Protein, in StatPearls. 2022, StatPearls Publishing
Copyright © 2022, StatPearls Publishing LLC.: Treasure Island (FL).
15. Zhang, Y., et al., C-Reactive Protein Levels Predict Responses to PD-1 Inhibitors in Hepatocellular Carcinoma Patients. Front Immunol, 2022. 13: p. 808101.
16. VanDevanter, D.R., et al., C-reactive protein (CRP) as a biomarker of pulmonary exacerbation presentation and treatment response. J Cyst Fibros, 2022. 21(4): p. 588-593.
17. Wang, Y., et al., Correlation between Changes in Serum RBP4, hs-CRP, and IL-27 Levels and Rosuvastatin in the Treatment of Coronary Heart Disease. J Healthc Eng, 2021. 2021: p. 8476592.
18. Quaglia, L.A., et al., C-reactive protein is independently associated with coronary atherosclerosis burden among octogenarians. Aging Clin Exp Res, 2014. 26(1): p. 19-23.
19. McKechnie, D.G., et al., Inflammatory markers and incident heart failure in older men: the role of NT-proBNP. Biomark Med, 2021. 15(6): p. 413-425.
20. Butler, C.C., et al., C-Reactive Protein Testing to Guide Antibiotic Prescribing for COPD Exacerbations. N Engl J Med, 2019. 381(2): p. 111-120.
21. Windgassen, E.B., et al., C-reactive protein and high-sensitivity C-reactive protein: an update for clinicians. Postgrad Med, 2011. 123(1): p. 114-9.
22. Vanmolkot, F.H. and J.N. de Hoon, Increased C-reactive protein in young adult patients with migraine. Cephalalgia, 2007. 27(7): p. 843-6.
23. Ahsen, A., et al., As a new inflammatory marker for familial Mediterranean fever: neutrophil-to-lymphocyte ratio. Inflammation, 2013. 36(6): p. 1357-62.
24. Borkum, J.M., Brain Energy Deficit as a Source of Oxidative Stress in Migraine: A Molecular Basis for Migraine Susceptibility. Neurochem Res, 2021. 46(8): p. 1913-1932.
25. Canpolat, U., et al., Role of preablation neutrophil/lymphocyte ratio on outcomes of cryoballoon-based atrial fibrillation ablation. Am J Cardiol, 2013. 112(4): p. 513-9.
26. Headache Classification Committee of the International Headache Society (IHS) The International Classification of Headache Disorders, 3rd edition. Cephalalgia, 2018. 38(1): p. 1-211.
27. Buture, A., et al., Current Understanding on Pain Mechanism in Migraine and Cluster Headache. Anesth Pain Med, 2016. 6(3): p. e35190.
28. Sanders, C.L., A. Ponte, and F. Kueppers, The Effects of Inflammation on Alpha 1 Antitrypsin Levels in a National Screening Cohort. Copd, 2018. 15(1): p. 10-16.
29. He, L., C. Fan, and G. Li, The relationship between serum C-reactive protein and senile hypertension. BMC Cardiovasc Disord, 2022. 22(1): p. 500.
30. Tanik, N., et al., Retinol-binding protein-4 and hs-CRP levels in patients with migraine. Neurol Sci, 2015. 36(10): p. 1823-7.
31. García-Ortega, D.Y., et al., Neutrophil/lymphocyte ratio is associated with survival in synovial sarcoma. Surg Oncol, 2018. 27(3): p. 551-555.
32. Imtiaz, F., et al., Neutrophil lymphocyte ratio as a measure of systemic inflammation in prevalent chronic diseases in Asian population. Int Arch Med, 2012. 5(1): p. 2.
33. Karabulut, K.U., et al., The change of neutrophils/lymphocytes ratio in migraine attacks: A case-controlled study. Ann Med Surg (Lond), 2016. 10: p. 52-6.
34. Bakirci, E.M., et al., The role of the nonspecific inflammatory markers in determining the anatomic extent of venous thromboembolism. Clin Appl Thromb Hemost, 2015. 21(2): p. 181-5.
2. Ghavami, Y., et al., Migraine features in patients with Meniere's disease. Laryngoscope, 2016. 126(1): p. 163-8.
3. Czapińska-Ciepiela, E., Treatment of migraine in a patient with epilepsy. Wiad Lek, 2018. 71(9): p. 1793-1802.
4. Karikari, T.K., et al., Commentary: Global, regional, and national burden of neurological disorders during 1990-2015: a systematic analysis for the Global Burden of Disease Study 2015. Front Neurol, 2018. 9: p. 201.
5. Hu, L., et al., Different Chinese patent medicine therapies for migraine: A protocol for systematic review and network meta-analysis. Medicine (Baltimore), 2021. 100(2): p. e24179.
6. Cameron, C., et al., Triptans in the Acute Treatment of Migraine: A Systematic Review and Network Meta-Analysis. Headache, 2015. 55 Suppl 4: p. 221-35.
7. Edvinsson, L., The Trigeminovascular Pathway: Role of CGRP and CGRP Receptors in Migraine. Headache, 2017. 57 Suppl 2: p. 47-55.
8. Abd Al-Kareem, T.A., S.A. Hassan, and S.M. Abdalhadi, Polycystic Ovary Syndrome: pathogenesis, management, and treatment with metals and organic compounds. Cell Mol Biomed Rep, 2024. 4(1): p. 54-64.
9. Li, W. and Y. Wang, The progress and development trends on stress granules in the world and China during the past 35 years. Cell Mol Biomed Rep, 2024. 4(1): p. 17-29.
10. Albeizanee, S., et al., Pathophysiological aspects of antioxidant glutathione system components during covid-19 infection; a patient-based survey and clinical relevance. Cell Mol Biomed Rep, 2025. 5(2): p. 103-112.
11. El-Seedy, A. and V. Ladeveze, CFTR complex alleles and phenotypic variability in cystic fibrosis disease: CFTR complex alleles. Cellular and Molecular Biology, 2024. 70(8): p. 244-260.
12. Panconesi, A., M.L. Bartolozzi, and L. Guidi, Migraine pain: reflections against vasodilatation. J Headache Pain, 2009. 10(5): p. 317-25.
13. Ramachandran, R., Neurogenic inflammation and its role in migraine. Semin Immunopathol, 2018. 40(3): p. 301-314.
14. Nehring, S.M., A. Goyal, and B.C. Patel, C Reactive Protein, in StatPearls. 2022, StatPearls Publishing
Copyright © 2022, StatPearls Publishing LLC.: Treasure Island (FL).
15. Zhang, Y., et al., C-Reactive Protein Levels Predict Responses to PD-1 Inhibitors in Hepatocellular Carcinoma Patients. Front Immunol, 2022. 13: p. 808101.
16. VanDevanter, D.R., et al., C-reactive protein (CRP) as a biomarker of pulmonary exacerbation presentation and treatment response. J Cyst Fibros, 2022. 21(4): p. 588-593.
17. Wang, Y., et al., Correlation between Changes in Serum RBP4, hs-CRP, and IL-27 Levels and Rosuvastatin in the Treatment of Coronary Heart Disease. J Healthc Eng, 2021. 2021: p. 8476592.
18. Quaglia, L.A., et al., C-reactive protein is independently associated with coronary atherosclerosis burden among octogenarians. Aging Clin Exp Res, 2014. 26(1): p. 19-23.
19. McKechnie, D.G., et al., Inflammatory markers and incident heart failure in older men: the role of NT-proBNP. Biomark Med, 2021. 15(6): p. 413-425.
20. Butler, C.C., et al., C-Reactive Protein Testing to Guide Antibiotic Prescribing for COPD Exacerbations. N Engl J Med, 2019. 381(2): p. 111-120.
21. Windgassen, E.B., et al., C-reactive protein and high-sensitivity C-reactive protein: an update for clinicians. Postgrad Med, 2011. 123(1): p. 114-9.
22. Vanmolkot, F.H. and J.N. de Hoon, Increased C-reactive protein in young adult patients with migraine. Cephalalgia, 2007. 27(7): p. 843-6.
23. Ahsen, A., et al., As a new inflammatory marker for familial Mediterranean fever: neutrophil-to-lymphocyte ratio. Inflammation, 2013. 36(6): p. 1357-62.
24. Borkum, J.M., Brain Energy Deficit as a Source of Oxidative Stress in Migraine: A Molecular Basis for Migraine Susceptibility. Neurochem Res, 2021. 46(8): p. 1913-1932.
25. Canpolat, U., et al., Role of preablation neutrophil/lymphocyte ratio on outcomes of cryoballoon-based atrial fibrillation ablation. Am J Cardiol, 2013. 112(4): p. 513-9.
26. Headache Classification Committee of the International Headache Society (IHS) The International Classification of Headache Disorders, 3rd edition. Cephalalgia, 2018. 38(1): p. 1-211.
27. Buture, A., et al., Current Understanding on Pain Mechanism in Migraine and Cluster Headache. Anesth Pain Med, 2016. 6(3): p. e35190.
28. Sanders, C.L., A. Ponte, and F. Kueppers, The Effects of Inflammation on Alpha 1 Antitrypsin Levels in a National Screening Cohort. Copd, 2018. 15(1): p. 10-16.
29. He, L., C. Fan, and G. Li, The relationship between serum C-reactive protein and senile hypertension. BMC Cardiovasc Disord, 2022. 22(1): p. 500.
30. Tanik, N., et al., Retinol-binding protein-4 and hs-CRP levels in patients with migraine. Neurol Sci, 2015. 36(10): p. 1823-7.
31. García-Ortega, D.Y., et al., Neutrophil/lymphocyte ratio is associated with survival in synovial sarcoma. Surg Oncol, 2018. 27(3): p. 551-555.
32. Imtiaz, F., et al., Neutrophil lymphocyte ratio as a measure of systemic inflammation in prevalent chronic diseases in Asian population. Int Arch Med, 2012. 5(1): p. 2.
33. Karabulut, K.U., et al., The change of neutrophils/lymphocytes ratio in migraine attacks: A case-controlled study. Ann Med Surg (Lond), 2016. 10: p. 52-6.
34. Bakirci, E.M., et al., The role of the nonspecific inflammatory markers in determining the anatomic extent of venous thromboembolism. Clin Appl Thromb Hemost, 2015. 21(2): p. 181-5.
Objavljeno
2025/07/07
Broj časopisa
Rubrika
Original paper
Sva prava zadržana (c) 2025 Yanluan Wan, Guanglan Liu, Chunfu Tao, Xiujuan Yuan, Haijian Zheng
Ovaj rad je pod Creative Commons Autorstvo 4.0 međunarodnom licencom.
The published articles will be distributed under the Creative Commons Attribution 4.0 International License (CC BY). It is allowed to copy and redistribute the material in any medium or format, and remix, transform, and build upon it for any purpose, even commercially, as long as appropriate credit is given to the original author(s), a link to the license is provided and it is indicated if changes were made. Users are required to provide full bibliographic description of the original publication (authors, article title, journal title, volume, issue, pages), as well as its DOI code. In electronic publishing, users are also required to link the content with both the original article published in Journal of Medical Biochemistry and the licence used.
Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.